Skip to main content
. 2021 Sep 17;11:721577. doi: 10.3389/fonc.2021.721577

Table 4.

Clinicopathological characteristics and survival data of NSCLC patients studied by immunohistochemistry.

Clinicopathological characteristics Total cases n (%)
Total 96 (100)
Age (years) Median (range) 67 (44–84)
Gender
Total 96 (100)
Male 90 (93.8)
Female 6 (6.2)
Smoking (pack-years)
Total 96 (100)
Cases (%) 39 (40.6)
Mean (range) 90.92 (20–165)
NA 57 (59.4)
Primary location
Total 96 (100)
Left lung 38 (39.6)
Right lung 58 (60.4)
NA
Histology
Total 96 (100)
Squamous 56 (58.3)
Adenocarcinoma 32 (33.3)
Large carcinoma 8 (8.3)
NA
Stage
Total 96 (100)
I 33 (34.4)
II 31 (32.3)
III 30 (31.3)
IV 2 (2.1)
NA
Grade
Total 96 (100)
I 4 (4.2)
II 42 (43.8)
III 42 (43.8)
NA 8 (8.3)
Maximum diameter (cm)
Total 96 (100)
Cases (%) 94 (98.0)
Mean (range) 5.34 (1.10–21.00)
NA 2 (2.0)
Lymph node infiltration
Total 96 (100)
No 49 (51.0)
Yes 43 (45.8)
NA 3 (3.1)
Metastasis (adrenals)
Total 96 (100)
No 17 (17.7)
Yes 1 (1.0)
NA 78 (81.3)
Metastasis (liver)
Total 96 (100)
No 17 (17.7)
Yes 3 (3.1)
NA 76 (79.2)
Metastasis (brain)
Total 96 (100)
No 17 (17.7)
Yes 6 (6.3)
NA 73 (76.0)
Metastasis (bones)
Total 96 (100)
No 13 (13.5)
Yes 11 (11.5)
NA 72 (75.0)
Metastasis (adrenals–liver–brain–bones)
Total 96 (100)
No 6 (6.3)
Yes 21 (21.9)
NA 69 (71.9)
Survival (2 years)
Total 96 (100)
Dead 37 (38.5)
Alive 57 (59.4)
NA 2 (2.1)
Survival (3 years)
Total 96 (100)
Dead 50 (52.1)
Alive 42 (43.8)
NA 4 (4.2)
Survival (5 years)
Total 96 (100)
Dead 59 (61.5)
Alive 33 (34.4)
NA 4 (4.2)
Relapse
Total 96 (100)
No 8 (8.3)
Yes 14 (14.6)
NA 74 (77.1)

NA, data not available or unknown.